Not applicableWithdrawnNCT06377202What this trial is testingLong-Term Follow-Up Safety Study of Subjects Treated with SynKIR-110 in Cancer StudiesWho this might be right forCancer Verismo Therapeutics
Testing effectiveness (Phase 2)Looking for participantsNCT07570862What this trial is testingA Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus NephritisWho this might be right forLupus NephritisSystemic Lupus ErythematosusSLE - Systemic Lupus Erythematosus+2 more Fate Therapeutics 53
Not applicableWithdrawnNCT06508346What this trial is testingStudy of Therapeutic Efficacy of Anti-CD19 CAR-T Cells in Children With Refractory Refractory AAVWho this might be right forANCA Associated VasculitisCAR-T Cell Therapy The Children's Hospital of Zhejiang University School of Medicine
Testing effectiveness (Phase 2)UnknownNCT02937103What this trial is testingA Clinical Research of CD123-Targeted CAR-T in Myeloid MalignanciesWho this might be right forLeukemia Southwest Hospital, China 45
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05459870What this trial is testingCAR-T Cells Targeting Autoimmune DiseasesWho this might be right forAutoimmune Diseases Shenzhen Geno-Immune Medical Institute 30
Testing effectiveness (Phase 2)UnknownNCT06149169What this trial is testingCD19-targeted CAR T Cells for Relapsed and Refractory (R/R) Large B-cell LymphomaWho this might be right forLymphoma, Non-HodgkinDiffuse Large B Cell Lymphoma Shanghai Ming Ju Biotechnology Co., Ltd. 10
Not applicableStudy completedNCT04468451What this trial is testingDoes Dosage Matter: Ride-on Cars to Enhance Social-mobility Function and Motivation in Toddlers With Motor DisabilitiesWho this might be right forMobility Limitation Chang Gung Memorial Hospital 13
Testing effectiveness (Phase 2)Ended earlyNCT06912529What this trial is testingAxicabtagene Ciloleucel CAR T-cells in Patients With Relapsed or Refractory Primary Mediastinal B-cell LymphomaWho this might be right forB-cell Lymphoma RefractoryB-cell Lymphoma Recurrent Universität Münster 1
Testing effectiveness (Phase 2)UnknownNCT03896854What this trial is testingCART-19 T Cell in CD19 Positive Relapsed or Refractory Acute Myeloid Leukemia (AML)Who this might be right forAcute Myeloid Leukemia Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd 15
Early research (Phase 1)Active Not RecruitingNCT03233854What this trial is testingCD19/CD22 Chimeric Antigen Receptor (CAR) T Cells With or Without NKTR-255 in Adults With Recurrent or Refractory B Cell MalignanciesWho this might be right forB Acute Lymphoblastic LeukemiaCD19 PositiveMinimal Residual Disease+1 more Stanford University 56
Early research (Phase 1)Not Yet RecruitingNCT06647329What this trial is testingCAR-T Technology for Recurrent/Refractory Malignant Hematological and Lymphatic TumorsWho this might be right forCAR-T Cell TherapyLymphomas Mingzhi Zhang 30
Early research (Phase 1)UnknownNCT04004637What this trial is testingCD7 CAR-T Cells for Patients With R/R CD7+ NK/T Cell Lymphoma,T-lymphoblastic Lymphoma and Acute Lymphocytic LeukemiaWho this might be right forT-lymphoblastic LymphomaNK/T Cell LymphomaAcute Lymphocytic Leukemia PersonGen BioTherapeutics (Suzhou) Co., Ltd. 10
Early research (Phase 1)UnknownNCT04385173What this trial is testingPilot Study of B7-H3 CAR-T in Treating Patients With Recurrent and Refractory GlioblastomaWho this might be right forRecurrent GlioblastomaRefractory Glioblastoma Second Affiliated Hospital, Zhejiang University, School of Medicine 12
Early research (Phase 1)Active Not RecruitingNCT05784441What this trial is testingJNJ-90009530 in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (r/r B-NHL)Who this might be right forRelapsed or Refractory B Cell Non-Hodgkin Lymphoma Janssen Research & Development, LLC 21
Testing effectiveness (Phase 2)Looking for participantsNCT07306156What this trial is testingGP350 CAR-T for Relapse/Refractory and Epstein-Barr Virus Infection Associated Lymphoid NeoplasmsWho this might be right forEBV Associated Lymphoid Neoplasms Zhimin Zhai 24
Very early researchNot Yet RecruitingNCT07266337What this trial is testingCD19/BCMA CAR-T for SLEWho this might be right forSLE - Systemic Lupus Erythematosus Chengdu Ucello Biotechnology Co., Ltd. 24
Early research (Phase 1)UnknownNCT05213195What this trial is testingNKG2D CAR-NK Cell Therapy in Patients With Refractory Metastatic Colorectal CancerWho this might be right forRefractory Metastatic Colorectal Cancer Zhejiang University 38
Testing effectiveness (Phase 2)Looking for participantsNCT07066995What this trial is testingMesothelin and Claudin 18.2 Dual-Target CAR-T Therapy in Advanced Pancreatic CancerWho this might be right forPancreatic CancerPancreatic CarcinomaPancreatic Cancer Non-resectable+1 more Essen Biotech 60
Very early researchNot Yet RecruitingNCT06886919What this trial is testingClinical Study Evaluating the Safety and Efficacy of IC19 CAR-T Cell Therapy for Refractory Systemic Lupus ErythematosusWho this might be right forDifficult to Treat Systemic Lupus Erythematosus Beijing Immunochina Medical Science & Technology Co., Ltd. 6
Early research (Phase 1)Active Not RecruitingNCT03617198What this trial is testingCD4 CAR+ ZFN-modified T Cells in HIV TherapyWho this might be right forHiv University of Pennsylvania 12